Funded equally by LUNGevity Foundation and the Thoracic Surgery Foundation
Sai Yendamuri, MD
State University of New York at Buffalo
Buffalo
Dr. Yendamuri is conducting a clinical trial among stage-1 non-small cell lung cancer patients to confirm a microRNA signature for the prediction of the recurrence of lung cancer after surgery. He then will develop a blood-based microRNA profile for the detection of lung cancer recurrence.